STUDIES ON ANTI-ATHEROSCLEROTIC AGENTS .2. EXPERIMENTAL STUDIES OF 1,3-PROPANEDIOL BIS(2 PARA CHLOROPHENOXYISOBUTYRATE) (CLY-503) FOR ANTI-ATHEROSCLEROTIC AGENTS

被引：2
|
作者：
NAKANISHI, M
KOBAYAKAWA, T
OKADA, T
GOTOH, K
机构：
来源：
YAKUGAKU ZASSHI | 1970年 / 90卷 / 08期
关键词：
D O I：
10.1248/yakushi1947.90.8_926
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：926 / +
页数：1
相关论文
共 50 条
  • [1] STUDIES ON ANTI-ATHEROSCLEROTIC AGENTS .1. STUDIES ON PHYSIOLOGICAL ACTIVITY OF ARYLOXYISOBUTYRATE
    NAKANISHI, M
    KOBAYAKAWA, T
    OKADA, T
    TSUMAGARI, T
    [J]. YAKUGAKU ZASSHI, 1970, 90 (08): : 921 - +
  • [2] EFFECTS OF 1,3-PROPANEDIOL BIS(ALPHA-P-CHLOROPHENOXYISOBUTYRATE) (CLY-503) ON CHOLESTEROL BIOSYNTHESIS IN RAT
    NAKANISH.M
    IMAMURA, H
    MATSUI, E
    IMAMURA, H
    MATSUI, E
    KATO, Y
    [J]. YAKUGAKU ZASSHI, 1970, 90 (03): : 267 - &
  • [3] QSAR Modeling of Sphingomyelin Synthase 2 Inhibitors for Their Potential as Anti-Atherosclerotic Agents
    Petrovic, Dejan
    Ilic, Marina Deljanin
    Simonovic, Dejan
    Marcetic, Zoran
    Stojanovic, Milovan
    Stojanovic, Sanja
    Arsic, Nebojsa
    Sokolovic, Dusan
    Veselinovic, Aleksandar M.
    [J]. ACTA CHIMICA SLOVENICA, 2024, 71 (01) : 170 - 178
  • [4] POTENTIAL ANTI-ATHEROSCLEROTIC AGENTS .2. (ARALKYLAMINO)BENZOIC AND (ALKYLAMINO)BENZOIC ACID ANALOGS OF CETABEN
    ALBRIGHT, JD
    DEVRIES, VG
    LARGIS, EE
    MINER, TG
    REICH, MF
    SCHAFFER, SA
    SHEPHERD, RG
    UPESLACIS, J
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1983, 26 (10) : 1378 - 1393
  • [5] STUDIES ON ANTI-ATHEROSCLEROTIC AGENTS .7. EXPERIMENTAL STUDIES OF SODIUM CHONDROITIN POLYSULFATE ON HYPOLIPEMIC, ANTICOAGULATIVE, FIBRINOLYTIC AND LIPOTROPIC ACTIVITIES
    KOBAYAKA.T
    [J]. YAKUGAKU ZASSHI, 1972, 92 (08): : 919 - &
  • [6] STUDIES ON ANTI-ATHEROSCLEROTIC AGENTS .9. SYNTHESIS OF 7-ETHOXYCARBONYL-4-HYDROXYMETHYL-6,8-DIMETHYL-1(2H)-PHTHALAZINONE (EG 626)
    ISHIKAWA, M
    EGUCHI, Y
    SUGIMOTO, A
    [J]. CHEMICAL & PHARMACEUTICAL BULLETIN, 1980, 28 (09) : 2770 - 2778
  • [7] Importance of acyl-coenzyme A:cholesterol acyltransferase 1/2 dual inhibition for anti-atherosclerotic potency of pactimibe
    Kitayama, Ken
    Tanimoto, Tatsuo
    Koga, Teiichiro
    Terasaka, Naoki
    Fujioka, Tomoyuki
    Inaba, Toshimori
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 540 (1-3) : 121 - 130
  • [8] Anti-atherosclerotic effects of LXRα agonist through induced conversion of M1 macrophage to M2
    Dou, Fangfang
    Chen, Jiulin
    Cao, Hui
    Jia, Qingling
    Shen, Dingzhu
    Liu, Te
    Chen, Chuan
    [J]. AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2019, 11 (06): : 3825 - 3840
  • [9] ANTI-INFLAMMATORY AGENTS IN EXPERIMENTAL ATHEROSCLEROSIS .2. FAILURE OF ANTIHYPERTENSIVE DRUGS TO EXACERBATE ATHEROSCLEROTIC PLAQUE-FORMATION
    BAILEY, JM
    RANDAZZO, R
    [J]. ATHEROSCLEROSIS, 1977, 26 (01) : 91 - 95
  • [10] STUDIES ON CHLORAMPHENICOL .5. SYNTHESIS OF ERYTHRO-1-PARA-NITROPHENYL-2-AMINO-1,3-PROPANEDIOL
    TATSUOKA, S
    MORIMOTO, A
    MIYAKE, A
    MIYAMOTO, M
    UEYANAGI, J
    SHIMADA, T
    MIYAZAKI, H
    [J]. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1951, 71 (08): : 776 - 778
12345